Diabetes-associated changes and role of Nɛ-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction
Authors:
- Yuta OzawaYOYuta Ozawa
- Kumiko TaguchiKTKumiko Taguchi
- Tsuneo KobayashiTKTsuneo Kobayashi
- Katsuo KamataKKKatsuo Kamata
Abstract
No abstract availableKeywords
Funding Information
- Takeda Science Foundation
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 56 references indexed in Scilit:
- Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin‐1‐induced vasoconstriction via ETA receptors and ERKBritish Journal of Pharmacology, 2008
- Gender differences in vascular reactivity to endothelin-1 (1-31) in mesenteric arteries from diabetic micePeptides, 2008
- Contrasting Actions of Endothelin ETAand ETBReceptors in Cardiovascular DiseaseAnnual Review of Pharmacology and Toxicology, 2007
- Enzymatic pathways involved in the generation of endothelin‐1(1–31) from exogenous big endothelin‐1 in the rabbit aortaBritish Journal of Pharmacology, 2006
- Cilostazol improves endothelium-derived hyperpolarizing factor-type relaxation in mesenteric arteries from diabetic ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Endothelin-1 (1-31) Is an Intermediate in the Production of Endothelin-1 After Big Endothelin-1 Administration In VivoHypertension, 2005
- N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue ProteinsBiochemistry, 1995
- Phosphoramidon-sensitive conversion of big endothelin-1 and degradation of endothelin-1 in rat kidney.Hypertension, 1994
- Enhanced secretion of endothelin‐1 by elevated glucose levels from cultured bovine aortic endothelial cellsFEBS Letters, 1990
- Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivoFEBS Letters, 1989